Onconetix (ONCO) Competitors $4.73 -1.57 (-24.90%) Closing price 04:00 PM EasternExtended Trading$4.86 +0.14 (+2.85%) As of 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONCO vs. SNYR, MTEX, SLGL, MRKR, BLRX, ELEV, ASBP, CING, LGVN, and CGTXShould you be buying Onconetix stock or one of its competitors? The main competitors of Onconetix include Synergy CHC Corp. (Uplisting) (SNYR), Mannatech (MTEX), Sol-Gel Technologies (SLGL), Marker Therapeutics (MRKR), BioLineRx (BLRX), Elevation Oncology (ELEV), Aspire Biopharma (ASBP), Cingulate (CING), Longeveron (LGVN), and Cognition Therapeutics (CGTX). These companies are all part of the "pharmaceutical products" industry. Onconetix vs. Its Competitors Synergy CHC Corp. (Uplisting) Mannatech Sol-Gel Technologies Marker Therapeutics BioLineRx Elevation Oncology Aspire Biopharma Cingulate Longeveron Cognition Therapeutics Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and Onconetix (NASDAQ:ONCO) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Does the media refer more to SNYR or ONCO? In the previous week, Synergy CHC Corp. (Uplisting) had 1 more articles in the media than Onconetix. MarketBeat recorded 9 mentions for Synergy CHC Corp. (Uplisting) and 8 mentions for Onconetix. Synergy CHC Corp. (Uplisting)'s average media sentiment score of 1.03 beat Onconetix's score of 0.39 indicating that Synergy CHC Corp. (Uplisting) is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synergy CHC Corp. (Uplisting) 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Onconetix 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor SNYR or ONCO? Synergy CHC Corp. (Uplisting) received 2 more outperform votes than Onconetix when rated by MarketBeat users. CompanyUnderperformOutperformSynergy CHC Corp. (Uplisting)Outperform Votes266.67% Underperform Votes133.33% OnconetixN/AN/A Do analysts prefer SNYR or ONCO? Synergy CHC Corp. (Uplisting) currently has a consensus price target of $10.00, indicating a potential upside of 380.77%. Given Synergy CHC Corp. (Uplisting)'s stronger consensus rating and higher possible upside, equities analysts plainly believe Synergy CHC Corp. (Uplisting) is more favorable than Onconetix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Onconetix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in SNYR or ONCO? 23.9% of Onconetix shares are owned by institutional investors. 56.6% of Synergy CHC Corp. (Uplisting) shares are owned by company insiders. Comparatively, 3.1% of Onconetix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, SNYR or ONCO? Synergy CHC Corp. (Uplisting) has higher revenue and earnings than Onconetix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynergy CHC Corp. (Uplisting)$33.59M0.57N/AN/AN/AOnconetix$2.52M120.95-$37.41MN/AN/A Is SNYR or ONCO more profitable? Synergy CHC Corp. (Uplisting) has a net margin of 0.00% compared to Onconetix's net margin of -2,758.89%. Company Net Margins Return on Equity Return on Assets Synergy CHC Corp. (Uplisting)N/A N/A N/A Onconetix -2,758.89%N/A -48.09% SummarySynergy CHC Corp. (Uplisting) beats Onconetix on 11 of the 13 factors compared between the two stocks. Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCO vs. The Competition Export to ExcelMetricOnconetixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$305.30M$6.88B$5.58B$8.50BDividend YieldN/A2.53%5.28%4.17%P/E RatioN/A8.5527.1919.64Price / Sales120.95262.61408.78152.17Price / CashN/A65.8538.3234.64Price / Book1.576.536.974.60Net Income-$37.41M$143.48M$3.23B$248.06M7 Day Performance-24.90%0.20%-0.88%-1.02%1 Month Performance-26.78%10.93%7.81%3.51%1 Year Performance-99.04%2.46%31.53%12.68% Onconetix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOOnconetix0.4418 of 5 stars$4.73-24.9%N/A-98.8%$305.30M$2.52M0.0012News CoverageEarnings ReportStock SplitShort Interest ↓Gap DownHigh Trading VolumeSNYRSynergy CHC Corp. (Uplisting)3.9076 of 5 stars$2.16+2.9%$10.00+363.0%N/A$19.86M$33.59M0.0040News CoveragePositive NewsGap UpMTEXMannatech1.4404 of 5 stars$10.39-2.6%N/A+19.5%$19.76M$115.04M-12.83250Positive NewsShort Interest ↓SLGLSol-Gel Technologies3.0091 of 5 stars$7.07-2.3%$40.00+465.8%-11.5%$19.70M$12.10M-20.7950Short Interest ↓MRKRMarker Therapeutics4.2853 of 5 stars$1.72-2.8%$13.17+665.5%-57.8%$19.46M$6.59M-1.2960Positive NewsBLRXBioLineRx3.4776 of 5 stars$5.93+3.3%$26.00+338.4%-79.8%$19.11M$22.34M-0.6740Gap DownHigh Trading VolumeELEVElevation Oncology3.3897 of 5 stars$0.38+20.1%$3.39+781.0%-88.7%$18.95MN/A-0.4740Trending NewsAnalyst ForecastShort Interest ↓Analyst RevisionHigh Trading VolumeASBPAspire BiopharmaN/A$0.40+3.8%N/AN/A$18.85MN/A0.00N/ANews CoverageGap DownCINGCingulate1.9415 of 5 stars$4.54+4.1%$26.00+472.7%+535.7%$18.51MN/A-0.5420Short Interest ↑Gap DownLGVNLongeveron3.5104 of 5 stars$1.27+3.3%$8.67+582.4%-27.1%$18.36M$2.23M-0.2020Gap UpCGTXCognition Therapeutics3.6475 of 5 stars$0.30+2.4%$5.63+1,760.7%-87.1%$18.31MN/A-0.3120Short Interest ↓Gap Up Related Companies and Tools Related Companies SNYR Alternatives MTEX Alternatives SLGL Alternatives MRKR Alternatives BLRX Alternatives ELEV Alternatives ASBP Alternatives CING Alternatives LGVN Alternatives CGTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCO) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONCO Stock Free ONCO Stock Alerts